@article{article, title = {{PCN259 SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY}}, publisher = {{Elsevier BV}}, url = {{}}, year = {{2019}}, month = {{5}}, author = {{Hatswell AJ and Bullement A and Schlichting M and Bharmal M}}, doi = {{10.1016/j.jval.2019.04.380}}, volume = {{22}}, journal = {{Value in Health}}, pages = {{S105-S105}}, note = {{Accessed on 2025/08/23}}}